Complement factor C5a induces atherosclerotic plaque disruptions

Complement factor C5a and its receptor C5aR are expressed in vulnerable atherosclerotic plaques; however, a causal relation between C5a and plaque rupture has not been established yet. Accelerated atherosclerosis was induced by placing vein grafts in male apoE−/− mice. After 24 days, when advanced p...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of cellular and molecular medicine Ročník 18; číslo 10; s. 2020 - 2030
Hlavní autori:	Wezel, Anouk, Vries, Margreet R., Lagraauw, H. Maxime, Foks, Amanda C., Kuiper, Johan, Quax, Paul H.A., Bot, Ilze
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England John Wiley & Sons, Inc 01.10.2014 BlackWell Publishing Ltd
Predmet:	Animals Apolipoprotein E Apolipoproteins E - physiology Apoptosis Arteriosclerosis Atherosclerosis C5a Cells, Cultured Complement C5a - genetics Complement C5a - metabolism Complement component C5a Endothelial cells Endothelium, Vascular - metabolism Endothelium, Vascular - pathology Hemorrhage Immunoenzyme Techniques Laboratory animals Male Mice Mice, Knockout Myocytes, Smooth Muscle - metabolism Myocytes, Smooth Muscle - pathology Original plaque rupture Plaque, Atherosclerotic - etiology Plaque, Atherosclerotic - metabolism Plaque, Atherosclerotic - pathology Plaques R&D Real-Time Polymerase Chain Reaction Receptor, Anaphylatoxin C5a - genetics Receptor, Anaphylatoxin C5a - metabolism Research & development Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - genetics Smooth muscle Surgery Veins & arteries Belgium United States > US Netherlands atherosclerosis plaque rupture apoptosis C5a
ISSN:	1582-1838, 1582-4934, 1582-4934
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	Complement factor C5a and its receptor C5aR are expressed in vulnerable atherosclerotic plaques; however, a causal relation between C5a and plaque rupture has not been established yet. Accelerated atherosclerosis was induced by placing vein grafts in male apoE−/− mice. After 24 days, when advanced plaques had developed, C5a or PBS was applied locally at the lesion site in a pluronic gel. Three days later mice were killed to examine the acute effect of C5a on late stage atherosclerosis. A significant increase in C5aR in the plaque was detectable in mice treated with C5a. Lesion size and plaque morphology did not differ between treatment groups, but interestingly, local treatment with C5a resulted in a striking increase in the amount of plaque disruptions with concomitant intraplaque haemorrhage. To identify the potential underlying mechanisms, smooth muscle cells and endothelial cells were treated in vitro with C5a. Both cell types revealed a marked increase in apoptosis after stimulation with C5a, which may contribute to lesion instability in vivo. Indeed, apoptosis within the plaque was seen to be significantly increased after C5a treatment. We here demonstrate a causal role for C5a in atherosclerotic plaque disruptions, probably by inducing apoptosis. Therefore, intervention in complement factor C5a signalling may be a promising target in the prevention of acute atherosclerotic complications.
AbstractList	Complement factor C5a and its receptor C5aR are expressed in vulnerable atherosclerotic plaques; however, a causal relation between C5a and plaque rupture has not been established yet. Accelerated atherosclerosis was induced by placing vein grafts in male apoE(-/-) mice. After 24 days, when advanced plaques had developed, C5a or PBS was applied locally at the lesion site in a pluronic gel. Three days later mice were killed to examine the acute effect of C5a on late stage atherosclerosis. A significant increase in C5aR in the plaque was detectable in mice treated with C5a. Lesion size and plaque morphology did not differ between treatment groups, but interestingly, local treatment with C5a resulted in a striking increase in the amount of plaque disruptions with concomitant intraplaque haemorrhage. To identify the potential underlying mechanisms, smooth muscle cells and endothelial cells were treated in vitro with C5a. Both cell types revealed a marked increase in apoptosis after stimulation with C5a, which may contribute to lesion instability in vivo. Indeed, apoptosis within the plaque was seen to be significantly increased after C5a treatment. We here demonstrate a causal role for C5a in atherosclerotic plaque disruptions, probably by inducing apoptosis. Therefore, intervention in complement factor C5a signalling may be a promising target in the prevention of acute atherosclerotic complications.Complement factor C5a and its receptor C5aR are expressed in vulnerable atherosclerotic plaques; however, a causal relation between C5a and plaque rupture has not been established yet. Accelerated atherosclerosis was induced by placing vein grafts in male apoE(-/-) mice. After 24 days, when advanced plaques had developed, C5a or PBS was applied locally at the lesion site in a pluronic gel. Three days later mice were killed to examine the acute effect of C5a on late stage atherosclerosis. A significant increase in C5aR in the plaque was detectable in mice treated with C5a. Lesion size and plaque morphology did not differ between treatment groups, but interestingly, local treatment with C5a resulted in a striking increase in the amount of plaque disruptions with concomitant intraplaque haemorrhage. To identify the potential underlying mechanisms, smooth muscle cells and endothelial cells were treated in vitro with C5a. Both cell types revealed a marked increase in apoptosis after stimulation with C5a, which may contribute to lesion instability in vivo. Indeed, apoptosis within the plaque was seen to be significantly increased after C5a treatment. We here demonstrate a causal role for C5a in atherosclerotic plaque disruptions, probably by inducing apoptosis. Therefore, intervention in complement factor C5a signalling may be a promising target in the prevention of acute atherosclerotic complications. Complement factor C5a and its receptor C5aR are expressed in vulnerable atherosclerotic plaques; however, a causal relation between C5a and plaque rupture has not been established yet. Accelerated atherosclerosis was induced by placing vein grafts in male apoE −/− mice. After 24 days, when advanced plaques had developed, C5a or PBS was applied locally at the lesion site in a pluronic gel. Three days later mice were killed to examine the acute effect of C5a on late stage atherosclerosis. A significant increase in C5aR in the plaque was detectable in mice treated with C5a. Lesion size and plaque morphology did not differ between treatment groups, but interestingly, local treatment with C5a resulted in a striking increase in the amount of plaque disruptions with concomitant intraplaque haemorrhage. To identify the potential underlying mechanisms, smooth muscle cells and endothelial cells were treated in vitro with C5a. Both cell types revealed a marked increase in apoptosis after stimulation with C5a, which may contribute to lesion instability in vivo . Indeed, apoptosis within the plaque was seen to be significantly increased after C5a treatment. We here demonstrate a causal role for C5a in atherosclerotic plaque disruptions, probably by inducing apoptosis. Therefore, intervention in complement factor C5a signalling may be a promising target in the prevention of acute atherosclerotic complications. Complement factor C5a and its receptor C5aR are expressed in vulnerable atherosclerotic plaques; however, a causal relation between C5a and plaque rupture has not been established yet. Accelerated atherosclerosis was induced by placing vein grafts in male apoE(-/-) mice. After 24 days, when advanced plaques had developed, C5a or PBS was applied locally at the lesion site in a pluronic gel. Three days later mice were killed to examine the acute effect of C5a on late stage atherosclerosis. A significant increase in C5aR in the plaque was detectable in mice treated with C5a. Lesion size and plaque morphology did not differ between treatment groups, but interestingly, local treatment with C5a resulted in a striking increase in the amount of plaque disruptions with concomitant intraplaque haemorrhage. To identify the potential underlying mechanisms, smooth muscle cells and endothelial cells were treated in vitro with C5a. Both cell types revealed a marked increase in apoptosis after stimulation with C5a, which may contribute to lesion instability in vivo. Indeed, apoptosis within the plaque was seen to be significantly increased after C5a treatment. We here demonstrate a causal role for C5a in atherosclerotic plaque disruptions, probably by inducing apoptosis. Therefore, intervention in complement factor C5a signalling may be a promising target in the prevention of acute atherosclerotic complications. Complement factor C5a and its receptor C5aR are expressed in vulnerable atherosclerotic plaques; however, a causal relation between C5a and plaque rupture has not been established yet. Accelerated atherosclerosis was induced by placing vein grafts in male apoE−/− mice. After 24 days, when advanced plaques had developed, C5a or PBS was applied locally at the lesion site in a pluronic gel. Three days later mice were killed to examine the acute effect of C5a on late stage atherosclerosis. A significant increase in C5aR in the plaque was detectable in mice treated with C5a. Lesion size and plaque morphology did not differ between treatment groups, but interestingly, local treatment with C5a resulted in a striking increase in the amount of plaque disruptions with concomitant intraplaque haemorrhage. To identify the potential underlying mechanisms, smooth muscle cells and endothelial cells were treated in vitro with C5a. Both cell types revealed a marked increase in apoptosis after stimulation with C5a, which may contribute to lesion instability in vivo. Indeed, apoptosis within the plaque was seen to be significantly increased after C5a treatment. We here demonstrate a causal role for C5a in atherosclerotic plaque disruptions, probably by inducing apoptosis. Therefore, intervention in complement factor C5a signalling may be a promising target in the prevention of acute atherosclerotic complications. Complement factor C5a and its receptor C5aR are expressed in vulnerable atherosclerotic plaques; however, a causal relation between C5a and plaque rupture has not been established yet. Accelerated atherosclerosis was induced by placing vein grafts in male apoE−/− mice. After 24 days, when advanced plaques had developed, C5a or PBS was applied locally at the lesion site in a pluronic gel. Three days later mice were killed to examine the acute effect of C5a on late stage atherosclerosis. A significant increase in C5aR in the plaque was detectable in mice treated with C5a. Lesion size and plaque morphology did not differ between treatment groups, but interestingly, local treatment with C5a resulted in a striking increase in the amount of plaque disruptions with concomitant intraplaque haemorrhage. To identify the potential underlying mechanisms, smooth muscle cells and endothelial cells were treated in vitro with C5a. Both cell types revealed a marked increase in apoptosis after stimulation with C5a, which may contribute to lesion instability in vivo. Indeed, apoptosis within the plaque was seen to be significantly increased after C5a treatment. We here demonstrate a causal role for C5a in atherosclerotic plaque disruptions, probably by inducing apoptosis. Therefore, intervention in complement factor C5a signalling may be a promising target in the prevention of acute atherosclerotic complications.
Author	Kuiper, Johan Quax, Paul H.A. Foks, Amanda C. Lagraauw, H. Maxime Vries, Margreet R. Wezel, Anouk Bot, Ilze
Author_xml	– sequence: 1 givenname: Anouk surname: Wezel fullname: Wezel, Anouk organization: Leiden University Medical Center – sequence: 2 givenname: Margreet R. surname: Vries fullname: Vries, Margreet R. organization: Leiden University Medical Center – sequence: 3 givenname: H. Maxime surname: Lagraauw fullname: Lagraauw, H. Maxime organization: Leiden University – sequence: 4 givenname: Amanda C. surname: Foks fullname: Foks, Amanda C. organization: Leiden University – sequence: 5 givenname: Johan surname: Kuiper fullname: Kuiper, Johan organization: Leiden University – sequence: 6 givenname: Paul H.A. surname: Quax fullname: Quax, Paul H.A. organization: Leiden University Medical Center – sequence: 7 givenname: Ilze surname: Bot fullname: Bot, Ilze organization: Leiden University Medical Center
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/25124749$$D View this record in MEDLINE/PubMed
BookMark	eNp9kU1LHTEUhkOx-FU3_QFloJsiXJuT79mUlsFWRemmrkNuJlNzyUymyUzFf29u71VUilkkB_Kcl_e85wDtDHFwCL0HfALlfF7Zvj8BQrl8g_aBK7JgNWU72xoUVXvoIOcVxlQArXfRHuFAmGT1PvraxH4MrnfDVHXGTjFVDTeVH9rZulyZ6calmG0o9-RtNQbzZ3ZV63Oax8nHIb9DbzsTsjvavofo-vvpr-Zscfnzx3nz7XJhOSi5MHzpuHOq7bCghgvBO8ZbilUnO3BOSsCyE9wUTioqJFMK2qWRNZeELQnQQ_RlozvOy961thhOJugx-d6kOx2N189_Bn-jf8e_mhHGMMgi8GkrkGKZIU-699m6EMzg4pw1iGKBCxCioB9foKs4p6GMpwmpMVAqBC7Uh6eOHq08hFsAvAFsiTAn12nrJ7NOrRj0QQPW6_3p9f70v_2VluMXLQ-q_4VhA9_64O5eIfVFc3W16bkHkgmq_w
CitedBy_id	crossref_primary_10_1016_j_humimm_2024_110765 crossref_primary_10_20538_1682_0363_2022_4_121_129 crossref_primary_10_1093_rheumatology_keaa092 crossref_primary_10_2147_PGPM_S307827 crossref_primary_10_1007_s12265_020_10001_y crossref_primary_10_1016_j_jconrel_2018_10_028 crossref_primary_10_1016_j_intimp_2023_110081 crossref_primary_10_1186_s40001_023_01043_4 crossref_primary_10_3109_09537104_2016_1148807 crossref_primary_10_3389_fimmu_2015_00045 crossref_primary_10_1038_nrneph_2017_17 crossref_primary_10_1016_j_molimm_2019_06_016 crossref_primary_10_1038_s41467_021_24960_6 crossref_primary_10_4110_in_2025_25_e32 crossref_primary_10_1007_s12026_015_8669_6 crossref_primary_10_1002_adhm_202000043 crossref_primary_10_1371_journal_pone_0172446 crossref_primary_10_3389_fimmu_2023_1103592 crossref_primary_10_5482_HAMO_14_08_0034 crossref_primary_10_1016_j_pharmthera_2019_03_008 crossref_primary_10_1038_s41569_024_01016_y crossref_primary_10_1038_nrcardio_2016_76 crossref_primary_10_3389_fcvm_2021_670045 crossref_primary_10_3390_ijms232112795 crossref_primary_10_1016_j_cytogfr_2020_08_003 crossref_primary_10_1038_srep24248 crossref_primary_10_4236_cm_2015_61007 crossref_primary_10_1007_s11883_025_01279_x crossref_primary_10_1055_s_0044_1788296 crossref_primary_10_1038_s41569_019_0249_3 crossref_primary_10_1111_all_14413 crossref_primary_10_1007_s00011_025_02069_6 crossref_primary_10_1038_s41467_022_33093_3 crossref_primary_10_1161_JAHA_124_038316 crossref_primary_10_3390_ijms22105122 crossref_primary_10_3390_jcdd11110337 crossref_primary_10_1016_j_atherosclerosis_2022_03_014 crossref_primary_10_3389_fcvm_2018_00003 crossref_primary_10_3389_fcvm_2021_731315 crossref_primary_10_1089_gtmb_2016_0125
Cites_doi	10.1096/fj.11-202382 10.1097/00001573-200109000-00006 10.1016/j.atherosclerosis.2011.11.024 10.1161/CIRCULATIONAHA.106.682054 10.1111/j.1538-7836.2010.04172.x 10.1161/CIRCRESAHA.108.175976 10.1096/fj.10-174284 10.1097/00041433-200410000-00011 10.1007/s00011-008-8156-9 10.1161/01.ATV.0000261709.34878.20 10.1146/annurev.immunol.23.021704.115835 10.1371/journal.pone.0047134 10.1016/S0735-1097(02)02834-6 10.1161/CIRCRESAHA.110.226282 10.1073/pnas.91.15.7291 10.1016/0003-2697(87)90021-2 10.4049/jimmunol.1102914 10.1111/j.1365-2796.2008.01965.x 10.1371/journal.pone.0002560 10.1007/BF02697367 10.1093/eurheartj/ehi339 10.1161/CIRCRESAHA.107.160697 10.1096/fj.10-156083 10.1371/journal.pone.0026095 10.1016/S0167-4889(02)00254-9 10.2741/2419 10.1038/nm1459 10.1371/journal.pone.0004953 10.1161/CIRCULATIONAHA.106.660472 10.1161/CIRCRESAHA.114.302355 10.1161/01.CIR.0000130172.62481.90 10.1161/ATVBAHA.112.250605 10.1016/S0092-8674(01)00238-0 10.1161/01.CIR.0000015502.97828.93 10.1194/jlr.M032862 10.1160/TH09-02-0103 10.1097/MOL.0b013e32830f4a06 10.1161/01.ATV.0000060200.73623.F8 10.1161/CIRCULATIONAHA.110.954370 10.1016/j.atherosclerosis.2009.07.030 10.1042/CS20040086 10.1161/ATVBAHA.108.179739 10.1161/CIRCULATIONAHA.112.124404 10.1161/01.CIR.0000019584.04929.83 10.1093/cvr/cvs312
ContentType	Journal Article
Copyright	2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. 2014. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. 2014
Copyright_xml	– notice: 2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. – notice: 2014. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. 2014
DBID	24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7TK 7X7 7XB 88E 88I 8AO 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U RC3 7X8 5PM
DOI	10.1111/jcmm.12357
DatabaseName	Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Science Database Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic CrossRef MEDLINE Publicly Available Content Database
Database_xml	– sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Biology
EISSN	1582-4934
EndPage	2030
ExternalDocumentID	PMC4244017 25124749 10_1111_jcmm_12357 JCMM12357
Genre	article Research Support, Non-U.S. Gov't Journal Article
GeographicLocations	Belgium United States--US Netherlands
GeographicLocations_xml	– name: Netherlands – name: United States--US – name: Belgium
GrantInformation_xml	– fundername: The Netherlands Heart Foundation funderid: 2010B029; 2010B244 – fundername: The Netherlands Organisation for Health Research and Development – fundername: Dutch Federation of University Medical Centres – fundername: The Netherlands CardioVascular Research Initiative – fundername: Dutch Heart Foundation – fundername: Royal Netherlands Academy of Sciences
GroupedDBID	--- 0R~ 1OC 24P 29K 31~ 36B 3V. 4.4 53G 5GY 5VS 7X7 8-0 8-1 88E 88I 8AO 8FE 8FH 8FI 8FJ 8R4 8R5 AAHHS AAZKR ABUWG ACCFJ ACCMX ACGFS ACGOD ACXQS ADBBV ADKYN ADPDF ADRAZ ADZMN ADZOD AEEZP AENEX AEQDE AFBPY AFKRA AFZJQ AHMBA AIWBW AJBDE ALAGY ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN AOIJS AVUZU AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI CAG CCPQU COF CS3 D-9 D-I DIK DU5 DWQXO E3Z EBD EBS EJD EMB EMOBN F5P FYUFA GNUQQ GODZA GROUPED_DOAJ HCIFZ HMCUK HYE HZ~ IAO IHR ITC KQ8 LH4 LK8 LW6 M1P M2P M48 M7P O9- OIG OK1 OVD OVEED PIMPY PQQKQ PROAC PSQYO Q2X RNS ROL RPM SV3 TEORI UKHRP WIN AAMMB AAYXX ABJNI AEFGJ AFFHD AGXDD AIDQK AIDYY CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7QP 7TK 7XB 8FD 8FK FR3 K9. P64 PKEHL PQEST PQUKI PRINS Q9U RC3 7X8 PUEGO 5PM
ID	FETCH-LOGICAL-c5187-a5be5ee8df063a5665f45d308f7f1ee77107f65aa5b783674881dba795724b213
IEDL.DBID	24P
ISICitedReferencesCount	44
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000343739200011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1582-1838 1582-4934
IngestDate	Tue Nov 04 01:38:41 EST 2025 Thu Sep 04 16:14:17 EDT 2025 Sat Nov 29 14:59:25 EST 2025 Mon Jul 21 05:23:07 EDT 2025 Sat Nov 29 02:51:28 EST 2025 Tue Nov 18 21:13:08 EST 2025 Wed Jan 22 16:22:26 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	10
Keywords	atherosclerosis plaque rupture apoptosis C5a
Language	English
License	Attribution http://creativecommons.org/licenses/by/3.0 2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c5187-a5be5ee8df063a5665f45d308f7f1ee77107f65aa5b783674881dba795724b213
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjcmm.12357
PMID	25124749
PQID	2290133660
PQPubID	2034150
PageCount	11
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_4244017 proquest_miscellaneous_1610756166 proquest_journals_2290133660 pubmed_primary_25124749 crossref_citationtrail_10_1111_jcmm_12357 crossref_primary_10_1111_jcmm_12357 wiley_primary_10_1111_jcmm_12357_JCMM12357
PublicationCentury	2000
PublicationDate	October 2014
PublicationDateYYYYMMDD	2014-10-01
PublicationDate_xml	– month: 10 year: 2014 text: October 2014
PublicationDecade	2010
PublicationPlace	England
PublicationPlace_xml	– name: England – name: Chichester – name: Oxford, UK
PublicationTitle	Journal of cellular and molecular medicine
PublicationTitleAlternate	J Cell Mol Med
PublicationYear	2014
Publisher	John Wiley & Sons, Inc BlackWell Publishing Ltd
Publisher_xml	– name: John Wiley & Sons, Inc – name: BlackWell Publishing Ltd
References	1987; 162 2012; 221 2012; 188 2010; 208 2010; 107 2006; 12 2013; 127 2008; 19 2010; 122 2006; 8 2008; 3 2008; 102 2012; 125 2005; 26 2004; 109 2004; 107 2011; 6 2008; 263 2007; 12 2001; 104 2012; 32 2014; 114 2005; 23 2007; 37 2011; 9 2007; 115 2009; 58 2002; 1591 2007; 116 2013; 54 2004; 15 2013; 97 2002; 105 2009; 102 2001; 16 2009; 4 2011; 25 2012; 26 2012; 7 1994; 91 2003; 41 2010; 30 2007; 27 2003; 23 e_1_2_7_6_1 Distelmaier K (e_1_2_7_10_1) 2009; 102 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_40_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_41_1 e_1_2_7_14_1 e_1_2_7_42_1 e_1_2_7_13_1 e_1_2_7_43_1 e_1_2_7_12_1 e_1_2_7_44_1 e_1_2_7_11_1 e_1_2_7_45_1 e_1_2_7_46_1 e_1_2_7_47_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 Roger VL (e_1_2_7_3_1) 2012; 125 e_1_2_7_29_1 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_32_1 e_1_2_7_23_1 e_1_2_7_33_1 e_1_2_7_22_1 e_1_2_7_34_1 e_1_2_7_21_1 e_1_2_7_35_1 e_1_2_7_20_1 e_1_2_7_36_1 e_1_2_7_37_1 e_1_2_7_38_1 e_1_2_7_39_1 Köhl J (e_1_2_7_48_1) 2006; 8 22196936 - Atherosclerosis. 2012 Mar;221(1):41-7 15230690 - Clin Sci (Lond). 2004 Oct;107(4):343-54 23224247 - Circulation. 2013 Jan 22;127(3):386-96 12644336 - J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):15S-22S 17873401 - Immunol Res. 2007;37(3):161-75 15771587 - Annu Rev Immunol. 2005;23:821-52 20813982 - FASEB J. 2011 Jan;25(1):35-44 19115040 - Inflamm Res. 2009 Jan;58(1):30-7 17485406 - Front Biosci. 2007;12:4696-708 18410595 - J Intern Med. 2008 May;263(5):517-27 22022523 - PLoS One. 2011;6(10):e26095 11980686 - Circulation. 2002 Apr 30;105(17):2064-70 8041783 - Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7291-5 18497329 - Circ Res. 2008 Jun 20;102(12):1529-38 24385514 - Circ Res. 2014 Jan 3;114(1):214-26 21071707 - Circ Res. 2010 Dec 10;107(12):e20-31 15361793 - Curr Opin Lipidol. 2004 Oct;15(5):567-73 20554950 - Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1282-92 22651932 - FASEB J. 2012 Sep;26(9):3680-90 17243489 - Curr Opin Mol Ther. 2006 Dec;8(6):529-38 2440339 - Anal Biochem. 1987 Apr;162(1):156-9 15917276 - Eur Heart J. 2005 Nov;26(21):2294-9 19718478 - Thromb Haemost. 2009 Sep;102(3):564-72 12615660 - Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):535-42 12183059 - Biochim Biophys Acta. 2002 Aug 19;1591(1-3):87-97 22652603 - Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1960-9 11239408 - Cell. 2001 Feb 23;104(4):503-16 23396975 - J Lipid Res. 2013 May;54(5):1265-74 18769228 - Curr Opin Lipidol. 2008 Oct;19(5):478-82 12081998 - Circulation. 2002 Jun 25;105(25):3025-31 21490292 - FASEB J. 2011 Jul;25(7):2447-55 19683238 - Atherosclerosis. 2010 Jan;208(1):285-9 15148270 - Circulation. 2004 Jun 1;109(21):2503-6 17332493 - Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):705-13 18648551 - PLoS One. 2008;3(7):e2560 22491257 - J Immunol. 2012 May 15;188(10):5086-93 17991882 - Circ Res. 2008 Feb 1;102(2):209-17 19308263 - PLoS One. 2009;4(3):e4953 23071737 - PLoS One. 2012;7(10):e47134 22179539 - Circulation. 2012 Jan 3;125(1):e2-e220 23071133 - Cardiovasc Res. 2013 Feb 1;97(2):311-20 20733098 - Circulation. 2010 Sep 7;122(10):1026-36 17470698 - Circulation. 2007 May 15;115(19):2516-25 17709641 - Circulation. 2007 Sep 11;116(11):1226-33 11584167 - Curr Opin Cardiol. 2001 Sep;16(5):285-92 21155967 - J Thromb Haemost. 2011 Mar;9(3):428-40 16892061 - Nat Med. 2006 Sep;12(9):1075-80
References_xml	– volume: 9 start-page: 428 year: 2011 end-page: 40 article-title: Complement in atherosclerosis: friend or foe? publication-title: J Thromb Haemost – volume: 6 start-page: e26095 year: 2011 article-title: Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE publication-title: PLoS ONE – volume: 8 start-page: 529 year: 2006 end-page: 38 article-title: Drug evaluation: the C5a receptor antagonist PMX‐53 publication-title: Curr Opin Mol Ther – volume: 12 start-page: 1075 year: 2006 end-page: 80 article-title: Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis publication-title: Nat Med – volume: 25 start-page: 35 year: 2011 end-page: 44 article-title: The complement component C5a is present in human coronary lesions and induces the expression of MMP‐1 and MMP‐9 in human macrophages publication-title: FASEB J – volume: 7 start-page: e47134 year: 2012 article-title: Plaque rupture complications in murine atherosclerotic vein grafts can be prevented by TIMP‐1 overexpression publication-title: PLoS ONE – volume: 58 start-page: 30 year: 2009 end-page: 7 article-title: Activation by C5a of endothelial cell caspase 8 and cFLIP publication-title: Inflamm Res – volume: 102 start-page: 1529 year: 2008 end-page: 38 article-title: Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration publication-title: Circ Res – volume: 162 start-page: 156 year: 1987 end-page: 9 article-title: Single‐step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction publication-title: Anal Biochem – volume: 107 start-page: 343 year: 2004 end-page: 54 article-title: Role of apoptosis in atherosclerosis and its therapeutic implications publication-title: Clin Sci – volume: 102 start-page: 564 year: 2009 end-page: 72 article-title: Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction publication-title: Thromb Haemost – volume: 30 start-page: 1282 year: 2010 end-page: 92 article-title: Concept of vulnerable/unstable plaque publication-title: Arterioscler Thromb Vasc Biol – volume: 125 start-page: e2 year: 2012 end-page: 220 article-title: Heart disease and stroke statistics–2012 update: a report from the American Heart Association publication-title: Circulation – volume: 1591 start-page: 87 year: 2002 end-page: 97 article-title: Targeting of peptides to restenotic vascular smooth muscle cells using phage display and publication-title: Biochim Biophys Acta – volume: 16 start-page: 285 year: 2001 end-page: 92 article-title: The thin‐cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes publication-title: Curr Opin Cardiol – volume: 26 start-page: 2294 year: 2005 end-page: 9 article-title: Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis publication-title: Eur Heart J – volume: 41 start-page: 15S year: 2003 end-page: 22S article-title: Mechanisms of plaque vulnerability and rupture publication-title: J Am Coll Cardiol – volume: 114 start-page: 214 year: 2014 end-page: 26 article-title: Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies publication-title: Circ Res – volume: 102 start-page: 209 year: 2008 end-page: 17 article-title: Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis publication-title: Circ Res – volume: 23 start-page: 535 year: 2003 end-page: 42 article-title: Rupture of the atherosclerotic plaque: does a good animal model exist? publication-title: Arterioscler Thromb Vasc Biol – volume: 208 start-page: 285 year: 2010 end-page: 9 article-title: Coronary late lumen loss of drug eluting stents is associated with increased serum levels of the complement components C3a and C5a publication-title: Atherosclerosis – volume: 107 start-page: e20 year: 2010 end-page: 31 article-title: Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR‐BI in Bone marrow‐derived cells in LDL receptor knockout mice on western‐type diet publication-title: Circ Res – volume: 27 start-page: 705 year: 2007 end-page: 13 article-title: Plaque rupture in humans and mice publication-title: Arterioscler Thromb Vasc Biol – volume: 127 start-page: 386 year: 2013 end-page: 96 article-title: Vascular smooth muscle cell sirtuin 1 protects against DNA damage and inhibits atherosclerosis publication-title: Circulation – volume: 263 start-page: 517 year: 2008 end-page: 27 article-title: The molecular mechanisms of the thrombotic complications of atherosclerosis publication-title: J Intern Med – volume: 26 start-page: 3680 year: 2012 end-page: 90 article-title: Generation of complement component C5a by ischemic neurons promotes neuronal apoptosis publication-title: FASEB J – volume: 3 start-page: e2560 year: 2008 article-title: The complement anaphylatoxin C5a induces apoptosis in adrenomedullary cells during experimental sepsis publication-title: PLoS ONE – volume: 32 start-page: 1960 year: 2012 end-page: 9 article-title: Mast cells induce vascular smooth muscle cell apoptosis a toll‐like receptor 4 activation pathway publication-title: Arterioscler Thromb Vasc Biol – volume: 116 start-page: 1226 year: 2007 end-page: 33 article-title: Increased endoplasmic reticulum stress in atherosclerotic plaques associated with acute coronary syndrome publication-title: Circulation – volume: 23 start-page: 821 year: 2005 end-page: 52 article-title: Role of C5a in inflammatory responses publication-title: Annu Rev Immunol – volume: 37 start-page: 161 year: 2007 end-page: 75 article-title: Anaphylatoxins: their role in bacterial infection and inflammation publication-title: Immunol Res – volume: 105 start-page: 3025 year: 2002 end-page: 31 article-title: Influence of C3 deficiency on atherosclerosis publication-title: Circulation – volume: 188 start-page: 5086 year: 2012 end-page: 93 article-title: Complement activation product C5a is a selective suppressor of TLR4‐induced, but not TLR3‐induced, production of IL‐27(p28) from macrophages publication-title: J Immunol – volume: 54 start-page: 1265 year: 2013 end-page: 74 article-title: Lysophosphatidic acid triggers mast cell‐driven atherosclerotic plaque destabilization by increasing vascular inflammation publication-title: J Lipid Res – volume: 115 start-page: 2516 year: 2007 end-page: 25 article-title: Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E‐deficient mice publication-title: Circulation – volume: 91 start-page: 7291 year: 1994 end-page: 5 article-title: Progressive growth in immunodeficient mice and host cell recruitment by mouse endothelial cells transformed by polyoma middle‐sized T antigen: implications for the pathogenesis of opportunistic vascular tumors publication-title: Proc Natl Acad Sci USA – volume: 109 start-page: 2503 year: 2004 end-page: 6 article-title: induction of endothelial apoptosis leads to vessel thrombosis and endothelial denudation: a clue to the understanding of the mechanisms of thrombotic plaque erosion publication-title: Circulation – volume: 221 start-page: 41 year: 2012 end-page: 7 article-title: The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis publication-title: Atherosclerosis – volume: 122 start-page: 1026 year: 2010 end-page: 36 article-title: C5a receptor targeting in neointima formation after arterial injury in atherosclerosis‐prone mice publication-title: Circulation – volume: 15 start-page: 567 year: 2004 end-page: 73 article-title: Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture publication-title: Curr Opin Lipidol – volume: 12 start-page: 4696 year: 2007 end-page: 708 article-title: Function and regulation of the complement system in cardiovascular diseases publication-title: Front Biosci – volume: 104 start-page: 503 year: 2001 end-page: 16 article-title: Atherosclerosis. the road ahead publication-title: Cell – volume: 105 start-page: 2064 year: 2002 end-page: 70 article-title: Induction of atherosclerotic plaque rupture in apolipoprotein E‐/‐ mice after adenovirus‐mediated transfer of p53 publication-title: Circulation – volume: 25 start-page: 2447 year: 2011 end-page: 55 article-title: Complement C5a inhibition reduces atherosclerosis in ApoE‐/‐ mice publication-title: FASEB J – volume: 19 start-page: 478 year: 2008 end-page: 82 article-title: The role of complement in atherosclerosis publication-title: Curr Opin Lipidol – volume: 4 start-page: e4953 year: 2009 article-title: C5a enhances dysregulated inflammatory and angiogenic responses to malaria : potential implications for placental malaria publication-title: PLoS ONE – volume: 97 start-page: 311 year: 2013 end-page: 20 article-title: Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease publication-title: Cardiovasc Res – ident: e_1_2_7_32_1 doi: 10.1096/fj.11-202382 – ident: e_1_2_7_42_1 doi: 10.1097/00001573-200109000-00006 – ident: e_1_2_7_25_1 doi: 10.1016/j.atherosclerosis.2011.11.024 – ident: e_1_2_7_41_1 doi: 10.1161/CIRCULATIONAHA.106.682054 – ident: e_1_2_7_9_1 doi: 10.1111/j.1538-7836.2010.04172.x – ident: e_1_2_7_44_1 doi: 10.1161/CIRCRESAHA.108.175976 – ident: e_1_2_7_16_1 doi: 10.1096/fj.10-174284 – ident: e_1_2_7_34_1 doi: 10.1097/00041433-200410000-00011 – ident: e_1_2_7_30_1 doi: 10.1007/s00011-008-8156-9 – ident: e_1_2_7_38_1 doi: 10.1161/01.ATV.0000261709.34878.20 – ident: e_1_2_7_12_1 doi: 10.1146/annurev.immunol.23.021704.115835 – ident: e_1_2_7_19_1 doi: 10.1371/journal.pone.0047134 – ident: e_1_2_7_36_1 doi: 10.1016/S0735-1097(02)02834-6 – ident: e_1_2_7_23_1 doi: 10.1161/CIRCRESAHA.110.226282 – ident: e_1_2_7_27_1 doi: 10.1073/pnas.91.15.7291 – ident: e_1_2_7_28_1 doi: 10.1016/0003-2697(87)90021-2 – ident: e_1_2_7_29_1 doi: 10.4049/jimmunol.1102914 – ident: e_1_2_7_6_1 doi: 10.1111/j.1365-2796.2008.01965.x – ident: e_1_2_7_31_1 doi: 10.1371/journal.pone.0002560 – ident: e_1_2_7_11_1 doi: 10.1007/BF02697367 – ident: e_1_2_7_18_1 doi: 10.1093/eurheartj/ehi339 – ident: e_1_2_7_22_1 doi: 10.1161/CIRCRESAHA.107.160697 – ident: e_1_2_7_40_1 doi: 10.1096/fj.10-156083 – ident: e_1_2_7_24_1 doi: 10.1371/journal.pone.0026095 – ident: e_1_2_7_26_1 doi: 10.1016/S0167-4889(02)00254-9 – ident: e_1_2_7_7_1 doi: 10.2741/2419 – ident: e_1_2_7_43_1 doi: 10.1038/nm1459 – ident: e_1_2_7_14_1 doi: 10.1371/journal.pone.0004953 – ident: e_1_2_7_20_1 doi: 10.1161/CIRCULATIONAHA.106.660472 – ident: e_1_2_7_37_1 doi: 10.1161/CIRCRESAHA.114.302355 – ident: e_1_2_7_46_1 doi: 10.1161/01.CIR.0000130172.62481.90 – ident: e_1_2_7_33_1 doi: 10.1161/ATVBAHA.112.250605 – volume: 8 start-page: 529 year: 2006 ident: e_1_2_7_48_1 article-title: Drug evaluation: the C5a receptor antagonist PMX‐53 publication-title: Curr Opin Mol Ther – ident: e_1_2_7_2_1 doi: 10.1016/S0092-8674(01)00238-0 – volume: 125 start-page: e2 year: 2012 ident: e_1_2_7_3_1 article-title: Heart disease and stroke statistics–2012 update: a report from the American Heart Association publication-title: Circulation – ident: e_1_2_7_4_1 doi: 10.1161/01.CIR.0000015502.97828.93 – ident: e_1_2_7_21_1 doi: 10.1194/jlr.M032862 – volume: 102 start-page: 564 year: 2009 ident: e_1_2_7_10_1 article-title: Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction publication-title: Thromb Haemost doi: 10.1160/TH09-02-0103 – ident: e_1_2_7_8_1 doi: 10.1097/MOL.0b013e32830f4a06 – ident: e_1_2_7_39_1 doi: 10.1161/01.ATV.0000060200.73623.F8 – ident: e_1_2_7_17_1 doi: 10.1161/CIRCULATIONAHA.110.954370 – ident: e_1_2_7_47_1 doi: 10.1016/j.atherosclerosis.2009.07.030 – ident: e_1_2_7_5_1 doi: 10.1042/CS20040086 – ident: e_1_2_7_35_1 doi: 10.1161/ATVBAHA.108.179739 – ident: e_1_2_7_45_1 doi: 10.1161/CIRCULATIONAHA.112.124404 – ident: e_1_2_7_13_1 doi: 10.1161/01.CIR.0000019584.04929.83 – ident: e_1_2_7_15_1 doi: 10.1093/cvr/cvs312 – reference: 21490292 - FASEB J. 2011 Jul;25(7):2447-55 – reference: 21071707 - Circ Res. 2010 Dec 10;107(12):e20-31 – reference: 23071133 - Cardiovasc Res. 2013 Feb 1;97(2):311-20 – reference: 22022523 - PLoS One. 2011;6(10):e26095 – reference: 17332493 - Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):705-13 – reference: 18497329 - Circ Res. 2008 Jun 20;102(12):1529-38 – reference: 17485406 - Front Biosci. 2007;12:4696-708 – reference: 17243489 - Curr Opin Mol Ther. 2006 Dec;8(6):529-38 – reference: 12081998 - Circulation. 2002 Jun 25;105(25):3025-31 – reference: 18410595 - J Intern Med. 2008 May;263(5):517-27 – reference: 22651932 - FASEB J. 2012 Sep;26(9):3680-90 – reference: 24385514 - Circ Res. 2014 Jan 3;114(1):214-26 – reference: 2440339 - Anal Biochem. 1987 Apr;162(1):156-9 – reference: 12183059 - Biochim Biophys Acta. 2002 Aug 19;1591(1-3):87-97 – reference: 15361793 - Curr Opin Lipidol. 2004 Oct;15(5):567-73 – reference: 8041783 - Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7291-5 – reference: 16892061 - Nat Med. 2006 Sep;12(9):1075-80 – reference: 15917276 - Eur Heart J. 2005 Nov;26(21):2294-9 – reference: 15771587 - Annu Rev Immunol. 2005;23:821-52 – reference: 19718478 - Thromb Haemost. 2009 Sep;102(3):564-72 – reference: 11980686 - Circulation. 2002 Apr 30;105(17):2064-70 – reference: 18648551 - PLoS One. 2008;3(7):e2560 – reference: 22652603 - Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1960-9 – reference: 17470698 - Circulation. 2007 May 15;115(19):2516-25 – reference: 12644336 - J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):15S-22S – reference: 19683238 - Atherosclerosis. 2010 Jan;208(1):285-9 – reference: 17991882 - Circ Res. 2008 Feb 1;102(2):209-17 – reference: 22491257 - J Immunol. 2012 May 15;188(10):5086-93 – reference: 15230690 - Clin Sci (Lond). 2004 Oct;107(4):343-54 – reference: 18769228 - Curr Opin Lipidol. 2008 Oct;19(5):478-82 – reference: 15148270 - Circulation. 2004 Jun 1;109(21):2503-6 – reference: 11584167 - Curr Opin Cardiol. 2001 Sep;16(5):285-92 – reference: 17709641 - Circulation. 2007 Sep 11;116(11):1226-33 – reference: 23396975 - J Lipid Res. 2013 May;54(5):1265-74 – reference: 20554950 - Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1282-92 – reference: 11239408 - Cell. 2001 Feb 23;104(4):503-16 – reference: 12615660 - Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):535-42 – reference: 22179539 - Circulation. 2012 Jan 3;125(1):e2-e220 – reference: 23071737 - PLoS One. 2012;7(10):e47134 – reference: 22196936 - Atherosclerosis. 2012 Mar;221(1):41-7 – reference: 19308263 - PLoS One. 2009;4(3):e4953 – reference: 23224247 - Circulation. 2013 Jan 22;127(3):386-96 – reference: 20733098 - Circulation. 2010 Sep 7;122(10):1026-36 – reference: 19115040 - Inflamm Res. 2009 Jan;58(1):30-7 – reference: 20813982 - FASEB J. 2011 Jan;25(1):35-44 – reference: 21155967 - J Thromb Haemost. 2011 Mar;9(3):428-40 – reference: 17873401 - Immunol Res. 2007;37(3):161-75
SSID	ssj0036139
Score	2.3198543
Snippet	Complement factor C5a and its receptor C5aR are expressed in vulnerable atherosclerotic plaques; however, a causal relation between C5a and plaque rupture has...
SourceID	pubmedcentral proquest pubmed crossref wiley
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	2020
SubjectTerms	Animals Apolipoprotein E Apolipoproteins E - physiology Apoptosis Arteriosclerosis Atherosclerosis C5a Cells, Cultured Complement C5a - genetics Complement C5a - metabolism Complement component C5a Endothelial cells Endothelium, Vascular - metabolism Endothelium, Vascular - pathology Hemorrhage Immunoenzyme Techniques Laboratory animals Male Mice Mice, Knockout Myocytes, Smooth Muscle - metabolism Myocytes, Smooth Muscle - pathology Original plaque rupture Plaque, Atherosclerotic - etiology Plaque, Atherosclerotic - metabolism Plaque, Atherosclerotic - pathology Plaques R&D Real-Time Polymerase Chain Reaction Receptor, Anaphylatoxin C5a - genetics Receptor, Anaphylatoxin C5a - metabolism Research & development Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger - genetics Smooth muscle Surgery Veins & arteries
SummonAdditionalLinks	– databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8NAEB60Knjx_YhWiehFIZo0j21OKsUiYksPKr2FJLuLhTapTSv4753ZpNFS6cVbIJNkszM7-83u7DcAF0JYnudz2_CEKQ3H55ZR5xSsIJiIfVtwoZLH355Zu13vdv1OseCWFWmVU5-oHDVPY1ojvyFecoynPM-8HX4YVDWKdleLEhrLsEIsCbZK3etMPbGNU5VfUJKq7J14MLims6FsdhKaQ5bzCZK_gauaeZqb_23zFmwUmFO_z41kG5ZEsgNreRXKr124I5-QZ5HrefkdveGGOgbrqPZMVxAxzfDJUYov0If9ENug8142muQZMXvw2nx4aTwaRWEFI3YtdCqhGwlXiDqXCFBCBHSudFxum3XJpCUEQ9TBpOeGKEeHPBgOcotHIfNdVnOimmXvQyVJE3EIOlGJci55jUh4rFD6PGLE6Y5hZ-xJ09fgctrTQVywjlPxi35QRh-olUBpRYPzUnaYc238KVWddnZQjLcs-OlpDc7K2zhSaPsjTEQ6yQLEtoiPPLRNDQ5y_ZafIZTnMAeby2Y0XwoQC_fsnaT3rti46aQgujUNrpSNLGh58NRotdTV0eJ_OIZ1xGVOnjNYhcp4NBEnsBp_jlG1p8rGvwHkCwZ0 priority: 102 providerName: ProQuest
Title	Complement factor C5a induces atherosclerotic plaque disruptions
URI	https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjcmm.12357 https://www.ncbi.nlm.nih.gov/pubmed/25124749 https://www.proquest.com/docview/2290133660 https://www.proquest.com/docview/1610756166 https://pubmed.ncbi.nlm.nih.gov/PMC4244017
Volume	18
WOSCitedRecordID	wos000343739200011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1582-4934 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036139 issn: 1582-1838 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1582-4934 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036139 issn: 1582-1838 databaseCode: M7P dateStart: 20000701 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1582-4934 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036139 issn: 1582-1838 databaseCode: BENPR dateStart: 20000701 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1582-4934 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036139 issn: 1582-1838 databaseCode: 7X7 dateStart: 20000701 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1582-4934 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036139 issn: 1582-1838 databaseCode: PIMPY dateStart: 20000701 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 1582-4934 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036139 issn: 1582-1838 databaseCode: M2P dateStart: 20000701 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest – providerCode: PRVWIB databaseName: Wiley Online Library Open Access customDbUrl: eissn: 1582-4934 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036139 issn: 1582-1838 databaseCode: 24P dateStart: 20000101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley Online Library website customDbUrl: eissn: 1582-4934 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0036139 issn: 1582-1838 databaseCode: WIN dateStart: 20000101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS9xAEB_UU_Cl1q8atUdEXyxEbvO1CfSh7aFoaY4g_Tifwia7SwXNycUr-N93ZjcXPCyF0pclx07uNjs7s7_Jzf4G4EQpFsepDLxYDbQXppJ5iaRgBcFElQZKKpM8_v0LH42S8TjNl-D9_CyM5YfoXriRZRh_TQYuyua5kVf392d00pMvQ4-xIKHCDX6Yz_1wgBtVathSEUPiwk1aclKTx9Pdu7gdvcCYL1Mln0NYswddbPzf6F_DqxZ7uh_tYtmEJVVvwZqtRvm0DR_IN9hscteW4XGHkXAxaEf1N66BipMG75xO8AvchzuBT-HK22Y6s5kxO_Dt4vzr8NJrCyx4VcTQuYioVJFSidQIVAQCu0iHkQwGieaaKcURfXAdRwLl6LAHR2NnshQ8jbgflj4LdmGlntRqD1yiFJVSS5_IeJjQqSw5cbtj-FnFepA6cDqf56Jq2cepCMZd0UUhOCOFmREHjjvZB8u58Uepw7m6itbumoLY6zHqjuOBA0ddN1oM_Q0iajWZNQViXMRJMa5RB95Y7XY_Q2gv5CEOly_ovRMgNu7Fnvr2p2HlphOD6N4ceGf0_peRF5-HWWau9v9F-ADWEa2FNpPwEFYepzP1FlarX4-o6L5Z-9jyMTdt0ofep_NRft03rxmwzXzqzzi2vfwqy2_w04-r0W8tyBAf
linkProvider	Wiley-Blackwell
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9tAEB5RSgWXFtrSmkdZ1PZAJbfxc-0DAhSKeCQRB0DcXMe7q0YCO8SEij_Fb2Rm13aJqLhx6M2SN_Y68-3MN_bsNwBfpHTCMBaeHcqWsv1YOHYkKFlBMpHFnhRSF4-fdXivF52fx8dTcFfvhaGyytonakctiozekf8gXXLMp8KwtTW8sqlrFH1drVtoGFgcyds_mLKVmwe7aN-vrrv386S9b1ddBewscHBFpUFfBlJGQmF0TpHNBMoPhNeKFFeOlBxDLldhkOI42uHAEeGO6Kc8Drjr913Hw-u-gJdII9xIlwoe157fw9AYVxKouloou7z8TntR-WTQe8RkHxdkPiTKOtLtvfnf_qN5eF1xarZjFsECTMn8LbwyXTZv38E2-TxTJc9MeyHWDlI2yAXCumSaAhcl_nJU4AXY8CLFZ2ZiUI7GpuLnPZw-y_QXYTovcvkRGEmlCqGESyJDTqpi0eekWY9pdRaqVmzBRm3ZJKtU1am5x0XSZFeIgkSjwILPzdih0RL556iV2rhJ5U_K5K9lLVhvTqMnoM87aS6LcZkgd0f-F-Las-CDwVNzG2KxPvdxunwCac0AUhmfPJMPfmu1cdoJiW7bgm8ak0_MPDlsd7v6aOnpZ1iD2f2TbifpHPSOlmEOOahv6iNXYPp6NJarMJPdXKOZP-n1xeDXc4P1HmxrYYg
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1NT9tAEB3RUKpeoAXamtJ2EXAAyRB_bnxAtAqNSoEoB0DcjOPdVSOBHeIExF_j13Vm13YbUXHj0Jslb-x15u3MG3v2DcCGlE4YRsKzQ9lUth8Jx24JSlaQTKSRJ4XUxePnx7zbbV1cRL0ZeKj2wlBZZeUTtaMWeUrvyHdJlxzzqTBs7qqyLKJ30Nkf3tjUQYq-tFbtNAxEjuT9HaZvxd7hAdp603U730_bP-yyw4CdBg6uriToy0DKllAYqRNkNoHyA-E1W4orR0qO4ZerMEhwHO124Ih2R_QTHgXc9fuu4-F1X8AsJ9FyXTbYq6KAh2EyKuVQdeVQen29Q_tS-XQAfMRqHxdn_k2addTrLPzP_9cbmC-5NvtmFsdbmJHZIsyZ7pv3S_CVfKGpnmem7RBrBwkbZALhXjBNjfMCfznK8QJseJXg8zMxKEYTUwm0DGfPMv130MjyTH4ARhKqQijhkviQk6hI9Dlp2WO6nYaqGVmwVVk5Tku1dWr6cRXXWRciItaIsGC9Hjs0GiP_HLVaGTou_UwR_7GyBWv1afQQ9NknyWQ-KWLk9MgLQ1yTFrw32KpvQ-zW5z5Ol0-hrh5A6uPTZ7LBL61CTjsk0Z1bsK3x-cTM45_tkxN9tPL0M3yBV4jR-Piwe_QRXiM19U3Z5Co0xqOJ_AQv09sxWvmzXmoMLp8bq78BA8hqRQ
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Complement+factor+C5a+induces+atherosclerotic+plaque+disruptions&rft.jtitle=Journal+of+cellular+and+molecular+medicine&rft.au=Wezel%2C+Anouk&rft.au=de+Vries%2C+Margreet+R&rft.au=Lagraauw%2C+H+Maxime&rft.au=Foks%2C+Amanda+C&rft.date=2014-10-01&rft.issn=1582-4934&rft.eissn=1582-4934&rft.volume=18&rft.issue=10&rft.spage=2020&rft_id=info:doi/10.1111%2Fjcmm.12357&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1582-1838&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1582-1838&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1582-1838&client=summon